Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane

Bone

Volumn 28, Issue 2, 2001, Pages 208-214

  O'Brien, E A ^a   Williams, J H H ^b   Marshall, M J ^a  

^a ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CHESTER   (United Kingdom)

Author keywords

Adhesion; Integrin; Osteoclast; Osteoprotegerin (OPG); Osteoprotegerin ligand (OPGL); Prostaglandin

Indexed keywords

CALCITRIOL; DEXAMETHASONE; INDOMETACIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PROSTAGLANDIN; PROSTAGLANDIN E2;

ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CELL ADHESION; CONTROLLED STUDY; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PERIOSTEUM; PROSTAGLANDIN SYNTHESIS; SKULL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD; CALCITRIOL; CALCIUM CHANNEL AGONISTS; CARRIER PROTEINS; CELL ADHESION; DINOPROSTONE; GLYCOPROTEINS; INDOMETHACIN; INTEGRIN BETA3; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; ORGAN CULTURE TECHNIQUES; OSTEOCLASTS; OSTEOPROTEGERIN; PARATHYROID HORMONE; PARIETAL BONE; PERIOSTEUM; PLATELET MEMBRANE GLYCOPROTEINS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0035137818     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00431-2     Document Type: Article

References (37)

1. Indomethacin inhibition of middle ear bone resorption
2. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast
3. Prostaglandins promote osteoclastlike cell formation by a mechanism involving cyclic adenosine 3′,5′-monophosphate in mouse bone marrow cell cultures
4. Studies on factors causing tooth resorption. 1. Role of prostaglandins as a chemical mediator on resorption of deciduous teeth in rabbits
5. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
6. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts
7. Antibody to β3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat
8. Relationship between interleukin-1 and prostaglandins in resorbing neonatal calvaria
9. Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts
10. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells; Potential paracrine mechanisms of glucocorticoid-induced osteoporosis
11. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
12. Integrin subunit β3 plays a crucial role in the movement of osteoclasts from the periosteum to the bone surface
13. Arg-GlyAsp (RGD) peptides and the antivitronectin receptor anti-body 23C6 inhibit dentine resorption and cell spreading by osteoclasts
14. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells
15. Mechanism of regulation of prostaglandin production by parathyroid hormone, interleukin-1, and cortisol in cultured mouse parietal bones
16. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
17. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis
18. TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption
19. Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation
20. Modification of the mouse calvarial technique improves responsiveness to stimulators of bone resorption
21. 3
22. Inhibition of prostaglandin synthesis leads to a change in adherence of mouse osteoclasts from bone to periosteum
23. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
24. Transforming growth factor-β1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells
25. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation
26. Osteoprotegerin ligand controls osteoclast adhesion to the bone surface in mouse calvaria
27. Role of prostaglandins in bone resorption in a synchronized remodeling sequence in the rat
28. Structure-activity studies of the s-echistatin inhibition of bone resorption
29. 2-Cl system of neutrophils is inhibited by indomethacin and other non-steroidal anti-inflammatory drugs
30. Osteoprotegerin; A novel secreted protein involved in the regulation of bone density
31. Indomethacin inhibition of tenotomy-induced bone resorption in rats
32. Growth factor-dependent activation of αvβ3 integrin in normal epithelial cells; Implications for tumor invasion
33. 2, or parathyroid hormone in the microenvironment of bone
34. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG); A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
35. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL